Acceptance and Commitment Therapy for individuals at risk for psychosis or with a first psychotic episode: A qualitative study on patients' perspectives
Early Intervention in Psychiatry · 2024
DOI: 10.1111/eip.13442 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Early Intervention in Psychiatry, 2024. Verfasst von Jara Bouws und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Arkin, Centre for Mental Health Care, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Acceptance and Commitment Therapy, Psychotic Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERC Consolidator Grant, ERC Proof-of-Concept Grant, Odysseus Grant.
Abstract (Originalsprache)
Aim
The aim of this qualitative study is to explore patients' perspectives on Acceptance and Commitment Therapy for early stages of psychosis. Therefore, we interviewed participants of the INTERACT study, that quantitatively investigated Acceptance and Commitment Therapy in Daily Life (ACT‐DL) in combination with treatment as usual, for early stages of psychosis, comparing it to treatment as usual.
Methods
Within 6 months after finishing ACT‐DL, we conducted semi‐structured, individual interviews with 19 participants. All interviews were audio‐recorded and transcribed. Thematic analysis was used for coding and analysis.
Results
Two overarching themes were formed: ‘the meaning of ACT’ and ‘what to improve’. Considering the first, participants generally understood and connected with the meaning of ACT, noticing more awareness and acceptance of their thoughts and feelings, and living more in line with their personal values. The second theme included comments on the protocol not being personal or psychosis specific enough and some elements of ACT being too difficult to understand when having active psychotic symptoms.
Conclusions
This study suggests that ACT is an acceptable and promising new form of treatment for early stages of psychosis, and it provides relevant information to further develop ACT for this group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research, Arkin, Centre for Mental Health Care, Amsterdam, The Netherlands.
- Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Neurosciences, Psychiatry Research Group, Centre for Contextual Psychiatry, KU Leuven, Leuven, Belgium.
- Department of Psychology, Leiden University, Leiden, The Netherlands.
- Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
ORCID-Profile: Jara Bouws
Förderung
- ERC Consolidator Grant
- ERC Proof-of-Concept Grant
- Odysseus Grant
- NWO VENI Grant
- DFG Heisenberg professorship
Zitieren
APA
Bouws, J., Henrard, A., de Koning, M., Schirmbeck, F., van Ghesel Grothe, S., van Aubel, E., Reininghaus, U., de Haan, L., & Myin-Germeys, I. (2024). Acceptance and Commitment Therapy for individuals at risk for psychosis or with a first psychotic episode: A qualitative study on patients' perspectives. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.13442
Vancouver
Bouws J, Henrard A, de Koning M, Schirmbeck F, van Ghesel Grothe S, van Aubel E, et al. Acceptance and Commitment Therapy for individuals at risk for psychosis or with a first psychotic episode: A qualitative study on patients' perspectives. Early Intervention in Psychiatry. 2024. doi:10.1111/eip.13442
BibTeX
@article{Bouws2024,
author = {Bouws, Jara and Henrard, Ann and de Koning, Mariken and Schirmbeck, Frederike and van Ghesel Grothe, Sophia and van Aubel, Evelyne and Reininghaus, Ulrich and de Haan, Lieuwe and Myin-Germeys, Inez},
title = {Acceptance and Commitment Therapy for individuals at risk for psychosis or with a first psychotic episode: A qualitative study on patients' perspectives},
journal = {Early Intervention in Psychiatry},
year = {2024},
doi = {10.1111/eip.13442}
}
EUVIMED